Loading people...
Kevin Dong is an early-stage venture capitalist and PhD-trained scientist operating within the United States biotechnology sector. He established his academic foundation by earning a Bachelor of Science degree in Physiological Psychology and Psychobiology from the University of California, Los Angeles (UCLA). Following his undergraduate studies, Dong advanced his scientific expertise by completing a Doctor of Philosophy in Biological and Biomedical Sciences at the Harvard University Graduate School of Arts and Sciences. Leveraging this rigorous academic research background, he transitioned into the venture capital industry to finance healthcare innovations and emerging life sciences startups. His professional investment strategy specifically targets early-stage companies that are actively developing novel therapeutic solutions for highly complex biological challenges. Dong maintains a primary focus on bridging the critical gap between institutional academic research and commercial startup funding to advance the biomedical ecosystem.
Kevin Dong is a dedicated Analyst at Apollo Health Ventures, a leading venture capital firm committed to building and investing in the future of health. In his role, Kevin is instrumental in the firm's investment process, contributing significantly to deal sourcing, due diligence, and market analysis. He works closely with the investment team to identify promising early-stage companies that are poised to make a substantial impact on healthcare outcomes.
At Apollo Health Ventures, Kevin's investment focus is broad yet targeted, encompassing critical areas within the life sciences and health technology sectors. He is particularly interested in biotechnology, including novel therapeutics and diagnostics, as well as the rapidly evolving field of digital health, which includes solutions for patient engagement, remote monitoring, and data analytics. Furthermore, Kevin explores opportunities in medical technology, looking for innovations that enhance patient care and operational efficiency. His work supports Apollo's strategy of backing companies that address significant unmet medical needs and have the potential for disruptive growth.
Kevin's career background reflects a strong foundation in understanding complex scientific and market landscapes, which is essential for evaluating high-potential health ventures. While specific details of his early career are not widely publicized, his role as an Analyst at Apollo Health Ventures suggests a robust analytical skill set combined with a passion for healthcare innovation. Analysts at such firms typically possess backgrounds in life sciences, finance, or related fields, often bringing experience from research, consulting, or prior roles within the healthcare industry. This diverse expertise enables them to assess both the scientific validity and commercial viability of potential investments.
Although specific notable investments directly attributed to Kevin Dong as an Analyst are typically part of the broader firm's portfolio, his contributions are vital to the success of Apollo Health Ventures' overall investment strategy. He plays a key part in the early stages of identifying and vetting companies that may eventually become significant players in the health ecosystem. Kevin's dedication to uncovering groundbreaking technologies and business models helps Apollo Health Ventures continue its mission of fostering innovation and driving progress in global health. His work is integral to the firm's ability to support entrepreneurs who are developing the next generation of healthcare solutions.
Kevin Dong is an Analyst at Apollo Health Ventures, a venture capital firm focused on building and investing in innovative health companies. He contributes to deal sourcing, due diligence, and market analysis for early-stage investments.
Kevin Dong's investment focus at Apollo Health Ventures includes early-stage companies in biotechnology, digital health, and medical technology. He seeks ventures with transformative potential in the healthcare sector.
Kevin Dong works as an Analyst at Apollo Health Ventures, a prominent venture capital firm dedicated to advancing healthcare innovation through strategic investments.
